Article info
Correspondence response
Response to : ‘Interleukin-4 as a emerging target for IgG4-related disease’ by Akiyama et al
- Correspondence to Ms Rachel S Simpson, Toronto Allergists, Toronto, ON M5G 1E2, Canada; rachel.simpson{at}queensu.ca
Citation
Response to : ‘Interleukin-4 as a emerging target for IgG4-related disease’ by Akiyama et al
Publication history
- Received January 27, 2020
- Accepted January 28, 2020
- First published February 7, 2020.
Online issue publication
January 12, 2022
Article Versions
- Previous version (7 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.